AMPLITUDE-O: Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
The Lancet Diabetes & Endocrinology
N Sattar, MMY Lee, SL Kristensen, KRH Branch, S Del Prato, NS Khurmi, CSP Lam, RD Lopes, JJV McMurray, RE Pratley, J Rosenstock, HC Gerstein
August 2021